The top 10 highest paid biopharma R&D executives in 2018
Most of the top research and development executives across the biopharma industry are earning around $7M a year. One would think that this list would correspond with the industry’s top R&D budgets, but that isn’t quite the case. See which execs made the top 10 list below:
- George Yancopoulos – Regeneron
- Paul Stoffels – Johnson & Johnson
- Michael Severino – AbbVie
- John McHutchison – Gilead Sciences
- Mikael Dolsten – Pfizer
- Michael Ehlers – Biogen
- Thomas Lynch – Bristol-Myers Squibb
- Roger Perlmutter – Merck & Co.
- Hal Barron – GlaxoSmithKline
- Jay Bradner – Novartis
